Clinical Trial Update: Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention [NA]

View source ↗

Summary

Clinical trial update reporting gastrointestinal ulceration events in patients receiving dual antiplatelet therapy after percutaneous coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Aspirin + P2Y12 inhibitor (dual antiplatelet therapy)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Acute Coronary Syndrome | NA | Status: COMPLETED